The new data comes from the phase 3 ALLEVIATE-1 trial, which compared cebranopadol to placebo for the management of moderate-to-severe acute pain following full abdominoplasty – a cosmetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback